{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:46:07Z","timestamp":1792107967970,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Thai Army and the Ministry of Higher Education, Science, Research and Innovation, Thailand"},{"name":"Medical Research Council","award":["MR\/K00414X\/1"],"award-info":[{"award-number":["MR\/K00414X\/1"]}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"crossref","award":["19891"],"award-info":[{"award-number":["19891"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016134","name":"FRAME","doi-asserted-by":"crossref","award":["RB03BK"],"award-info":[{"award-number":["RB03BK"]}],"id":[{"id":"10.13039\/501100016134","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High expression of polymeric immunoglobulin receptor (PIGR) in breast cancer is associated with increased 5-year survival rate. However, the factors influencing PIGR expression in breast cancer have not been elucidated. The aim of this study was to determine the role of macrophages and cytokines affecting expression of PIGR in two\u00a0breast cancer cell lines. M1, M2 macrophage conditioned media (CM) and recombinant human cytokines were used to determine factors which increased PIGR expression in MCF7 (HTB-22) and MDA-MB468 (HTB-132) breast cancer cell lines. The level of PIGR expression in the cells and PIGR secretory component were evaluated by real-time quantitative polymerase chain reaction and Western blotting. M1 macrophage CM induced a dose-dependent increase in PIGR mRNA expression in MDA-MB468 cells, up to 20-fold. The level of PIGR expression in MCF7 cells was very low and not affected by M1 and M2 CM. Interferon gamma (IFN-\u03b3) and interleukin (IL)-1\u03b2 also increased PIGR expression in MDA-MB468 and MCF7 cells. However, IL-1\u03b2 was demonstrated to increase in M1 macrophages, while IFN-\u03b3 was not. The role of IL-1\u03b2 secreted from M1 macrophages in increasing expression of PIGR was confirmed by IL-1 receptor blockade, indicating that IL-1\u03b2 was the major M1 macrophage-derived cytokine that enhanced PIGR expression. Elevated PIGR expression in breast cancer in vivo may reflect the polarization state of tumor-associated immune cells.<\/jats:p>","DOI":"10.1038\/s41598-022-20811-6","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:02:46Z","timestamp":1665140566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1\u03b2"],"prefix":"10.1038","volume":"12","author":[{"given":"Wichitra","family":"Asanprakit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep N.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Eremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"20811_CR1","first-page":"47","volume":"105","author":"JP Harris","year":"1981","unstructured":"Harris, J. P. & South, M. A. Secretory component: A glandular epithelial cell marker. Am. J. Pathol. 105, 47\u201353 (1981).","journal-title":"Am. J. Pathol."},{"key":"20811_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","volume":"206","author":"CS Kaetzel","year":"2005","unstructured":"Kaetzel, C. S. The polymeric immunoglobulin receptor: Bridging innate and adaptive immune responses at mucosal surfaces. Immunol. Rev. 206, 83\u201399. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00278.x (2005).","journal-title":"Immunol. Rev."},{"key":"20811_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1600-065X.2011.01072.x","volume":"245","author":"AJ Macpherson","year":"2012","unstructured":"Macpherson, A. J., Geuking, M. B., Slack, E., Hapfelmeier, S. & McCoy, K. D. The habitat, double life, citizenship and forgetfulness of IgA. Immunol. Rev. 245, 132\u2013146. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01072.x (2012).","journal-title":"Immunol. Rev."},{"key":"20811_CR4","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/jnci\/djr360","volume":"103","author":"J Ai","year":"2011","unstructured":"Ai, J. et al. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. J. Natl. Cancer. Inst. 103, 1696\u20131712. https:\/\/doi.org\/10.1093\/jnci\/djr360 (2011).","journal-title":"J. Natl. Cancer. Inst."},{"key":"20811_CR5","first-page":"652","volume":"61","author":"F Liu","year":"2014","unstructured":"Liu, F. et al. Colorectal polymeric immunoglobulin receptor expression is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis. Hepatogastroenterology 61, 652\u2013659 (2014).","journal-title":"Hepatogastroenterology"},{"key":"20811_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3892\/mmr.2014.2110","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang, X., Du, J., Gu, P., Jin, R. & Lin, X. Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma. Mol. Med. Rep. 9, 2105\u20132110. https:\/\/doi.org\/10.3892\/mmr.2014.2110 (2014).","journal-title":"Mol. Med. Rep."},{"key":"20811_CR7","first-page":"2185","volume":"7","author":"H Niu","year":"2014","unstructured":"Niu, H., Wang, K. & Wang, Y. Polymeric immunoglobulin receptor expression is predictive of poor prognosis in glioma patients. Int. J. Clin. Exp. Med. 7, 2185\u20132190 (2014).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"20811_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1479-5876-12-83","volume":"12","author":"R Fristedt","year":"2014","unstructured":"Fristedt, R. et al. Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma. J. Transl. Med. 12, 83. https:\/\/doi.org\/10.1186\/1479-5876-12-83 (2014).","journal-title":"J. Transl. Med."},{"key":"20811_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.5858\/2008-132-1295-PIRTRA","volume":"132","author":"A Gologan","year":"2008","unstructured":"Gologan, A., Acquafondata, M., Dhir, R. & Sepulveda, A. R. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction. Arch. Pathol. Lab. Med. 132, 1295\u20131301. https:\/\/doi.org\/10.5858\/2008-132-1295-PIRTRA (2008).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"20811_CR10","doi-asserted-by":"publisher","first-page":"e112728","DOI":"10.1371\/journal.pone.0112728","volume":"9","author":"R Fristedt","year":"2014","unstructured":"Fristedt, R. et al. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis. PLoS ONE 9, e112728. https:\/\/doi.org\/10.1371\/journal.pone.0112728 (2014).","journal-title":"PLoS ONE"},{"key":"20811_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1074\/mcp.M600378-MCP200","volume":"6","author":"LV DeSouza","year":"2007","unstructured":"DeSouza, L. V. et al. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteom. 6, 1170\u20131182. https:\/\/doi.org\/10.1074\/mcp.M600378-MCP200 (2007).","journal-title":"Mol. Cell. Proteom."},{"key":"20811_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1757-2215-7-26","volume":"7","author":"J Berntsson","year":"2014","unstructured":"Berntsson, J. et al. Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer. J. Ovarian Res. 7, 26. https:\/\/doi.org\/10.1186\/1757-2215-7-26 (2014).","journal-title":"J. Ovarian Res."},{"key":"20811_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1183\/09031936.00184410","volume":"39","author":"S Ocak","year":"2012","unstructured":"Ocak, S. et al. Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis. Eur. Respir. J. 39, 1171\u20131180. https:\/\/doi.org\/10.1183\/09031936.00184410 (2012).","journal-title":"Eur. Respir. J."},{"key":"20811_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11373-004-8185-5","volume":"12","author":"NH Khattar","year":"2005","unstructured":"Khattar, N. H., Lele, S. M. & Kaetzel, C. S. Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: Correlation with dysregulated expression of the transcription factors USF and AP2. J. Biomed. Sci. 12, 65\u201377. https:\/\/doi.org\/10.1007\/s11373-004-8185-5 (2005).","journal-title":"J. Biomed. Sci."},{"key":"20811_CR15","first-page":"1861","volume":"35","author":"JP Harris","year":"1975","unstructured":"Harris, J. P., Caleb, M. H. & South, M. A. Secretory component in human mammary carcinoma. Cancer Res. 35, 1861\u20131864 (1975).","journal-title":"Cancer Res."},{"key":"20811_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0002-9378(79)90864-0","volume":"134","author":"EA Puleo","year":"1979","unstructured":"Puleo, E. A., Haagensen, D. E. Jr., Dawson, J. R. & Gall, S. A. Study of secretory component in patients with metastatic breast cancer. Am. J. Obstet. Gynecol. 134, 899\u2013903. https:\/\/doi.org\/10.1016\/0002-9378(79)90864-0 (1979).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"20811_CR17","unstructured":"The Human Protein Atlas. PIGR, Pathology Version 20.1. https:\/\/www.proteinatlas.org\/ENSG00000162896-PIGR\/pathology\/breast+cancer (Accessed 5 August 2021)."},{"key":"20811_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fimmu.2014.00127","volume":"5","author":"E Van Overmeire","year":"2014","unstructured":"Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A. & Sarukhan, A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front. Immunol. 5, 127. https:\/\/doi.org\/10.3389\/fimmu.2014.00127 (2014).","journal-title":"Front. Immunol."},{"key":"20811_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958\u2013969. https:\/\/doi.org\/10.1038\/nri2448 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"20811_CR20","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J. Immunol. 164, 6166\u20136173. https:\/\/doi.org\/10.4049\/jimmunol.164.12.6166 (2000).","journal-title":"J. Immunol."},{"key":"20811_CR21","doi-asserted-by":"publisher","first-page":"50323","DOI":"10.3791\/50323","volume":"76","author":"W Ying","year":"2013","unstructured":"Ying, W., Cheruku, P. S., Bazer, F. W., Safe, S. H. & Zhou, B. Investigation of macrophage polarization using bone marrow derived macrophages. J. Vis. Exp. 76, 50323. https:\/\/doi.org\/10.3791\/50323 (2013).","journal-title":"J. Vis. Exp."},{"key":"20811_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541\u2013566. https:\/\/doi.org\/10.1146\/annurev-physiol-022516-034339 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"20811_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196, 254\u2013265. https:\/\/doi.org\/10.1002\/path.1027 (2002).","journal-title":"J. Pathol."},{"key":"20811_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4048\/jbc.2019.22.e5","volume":"22","author":"H Jeong","year":"2019","unstructured":"Jeong, H., Hwang, I., Kang, S. H., Shin, H. C. & Kwon, S. Y. Tumor-associated macrophages as potential prognostic biomarkers of invasive breast cancer. J. Breast Cancer 22, 38\u201351. https:\/\/doi.org\/10.4048\/jbc.2019.22.e5 (2019).","journal-title":"J. Breast Cancer"},{"key":"20811_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-012-2190-6","volume":"135","author":"SD Heys","year":"2012","unstructured":"Heys, S. D. et al. Characterisation of tumour-infiltrating macrophages: Impact on response and survival in patients receiving primary chemotherapy for breast cancer. Breast Cancer Res. Treat. 135, 539\u2013548. https:\/\/doi.org\/10.1007\/s10549-012-2190-6 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"20811_CR26","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/mi.2011.37","volume":"4","author":"FE Johansen","year":"2011","unstructured":"Johansen, F. E. & Kaetzel, C. S. Regulation of the polymeric immunoglobulin receptor and IgA transport: New advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol. 4, 598\u2013602. https:\/\/doi.org\/10.1038\/mi.2011.37 (2011).","journal-title":"Mucosal Immunol."},{"key":"20811_CR27","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas, G., Germano, G., Mantovani, A. & Allavena, P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065\u20131073. https:\/\/doi.org\/10.1189\/jlb.0609385 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"20811_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 11, 889\u2013896. https:\/\/doi.org\/10.1038\/ni.1937 (2010).","journal-title":"Nat. Immunol."},{"key":"20811_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73 (2008).","journal-title":"Nat. Protoc."},{"key":"20811_CR30","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai, X., Cheng, H., Bai, Z. & Li, J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J. Cancer 8, 3131\u20133141. https:\/\/doi.org\/10.7150\/jca.18457 (2017).","journal-title":"J. Cancer"},{"key":"20811_CR31","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.4049\/jimmunol.138.12.4303","volume":"138","author":"LM Sollid","year":"1987","unstructured":"Sollid, L. M., Kvale, D., Brandtzaeg, P., Markussen, G. & Thorsby, E. Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J. Immunol. 138, 4303\u20134306 (1987).","journal-title":"J. Immunol."},{"key":"20811_CR32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.4049\/jimmunol.145.6.1740","volume":"145","author":"JO Phillips","year":"1990","unstructured":"Phillips, J. O., Everson, M. P., Moldoveanu, Z., Lue, C. & Mestecky, J. Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J. Immunol. 145, 1740\u20131744 (1990).","journal-title":"J. Immunol."},{"key":"20811_CR33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.162.3.1232","volume":"162","author":"VJ Blanch","year":"1999","unstructured":"Blanch, V. J., Piskurich, J. F. & Kaetzel, C. S. Cutting edge: Coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines. J. Immunol. 162, 1232\u20131235 (1999).","journal-title":"J. Immunol."},{"key":"20811_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0161-5890(93)90071-i","volume":"30","author":"JF Piskurich","year":"1993","unstructured":"Piskurich, J. F. et al. Interferon-gamma induces polymeric immunoglobulin receptor mRNA in human intestinal epithelial cells by a protein synthesis dependent mechanism. Mol. Immunol. 30, 413\u2013421. https:\/\/doi.org\/10.1016\/0161-5890(93)90071-i (1993).","journal-title":"Mol. Immunol."},{"key":"20811_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0161-5890(96)00079-x","volume":"34","author":"JF Piskurich","year":"1997","unstructured":"Piskurich, J. F. et al. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-gamma. Mol. Immunol. 34, 75\u201391. https:\/\/doi.org\/10.1016\/s0161-5890(96)00079-x (1997).","journal-title":"Mol. Immunol."},{"key":"20811_CR36","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.4049\/jimmunol.162.9.5112","volume":"162","author":"LW Ackermann","year":"1999","unstructured":"Ackermann, L. W., Wollenweber, L. A. & Denning, G. M. IL-4 and IFN-gamma increase steady state levels of polymeric Ig receptor mRNA in human airway and intestinal epithelial cells. J. Immunol. 162, 5112\u20135118 (1999).","journal-title":"J. Immunol."},{"key":"20811_CR37","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1365-2567.1997.00341.x","volume":"92","author":"M Hayashi","year":"1997","unstructured":"Hayashi, M. et al. The polymeric immunoglobulin receptor (secretory component) in a human intestinal epithelial cell line is up-regulated by interleukin-1. Immunology 92, 220\u2013225. https:\/\/doi.org\/10.1046\/j.1365-2567.1997.00341.x (1997).","journal-title":"Immunology"},{"key":"20811_CR38","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.4049\/jimmunol.140.9.3086","volume":"140","author":"D Kvale","year":"1988","unstructured":"Kvale, D., Lovhaug, D., Sollid, L. M. & Brandtzaeg, P. Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J. Immunol. 140, 3086\u20133089 (1988).","journal-title":"J. Immunol."},{"key":"20811_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1073\/pnas.1812266115","volume":"116","author":"I Kaplanov","year":"2019","unstructured":"Kaplanov, I. et al. Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc. Natl. Acad. Sci. U.S.A. 116, 1361\u20131369. https:\/\/doi.org\/10.1073\/pnas.1812266115 (2019).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"20811_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2741\/1845","volume":"11","author":"D Roy","year":"2006","unstructured":"Roy, D., Sarkar, S. & Felty, Q. Levels of IL-1 beta control stimulatory\/inhibitory growth of cancer cells. Front. Biosci. 11, 889\u2013898. https:\/\/doi.org\/10.2741\/1845 (2006).","journal-title":"Front. Biosci."},{"issue":"Suppl 1","key":"20811_CR41","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.2119\/molmed.2014.00232","volume":"20","author":"CA Dinarello","year":"2014","unstructured":"Dinarello, C. A. An expanding role for interleukin-1 blockade from gout to cancer. Mol. Med. 20(Suppl 1), S43\u2013S58. https:\/\/doi.org\/10.2119\/molmed.2014.00232 (2014).","journal-title":"Mol. Med."},{"key":"20811_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/cr.2008.275","volume":"18","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Repression of interferon-gamma expression in T cells by prospero-related homeobox protein. Cell. Res. 18, 911\u2013920. https:\/\/doi.org\/10.1038\/cr.2008.275 (2008).","journal-title":"Cell. Res."},{"key":"20811_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/ijms19010089","volume":"19","author":"M Mojic","year":"2017","unstructured":"Mojic, M., Takeda, K. & Hayakawa, Y. The dark side of IFN-gamma: Its role in promoting cancer immunoevasion. Int. J. Mol. Sci. 19, 89. https:\/\/doi.org\/10.3390\/ijms19010089 (2017).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20811-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T10:05:28Z","timestamp":1677060328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20811-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"12 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16842"}}